Michael Har-Noy

3PUBLICATIONS
0CO-AUTHORS
Molecular targetsMajor global burdens of diseasePreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 27, 2026
Generating Patient-Specific Anti-Tumor Responses with Non-Genetically Altered 'Off-the-Shelf' Allogeneic Cell Therapy: Leveraging Allo-Incompatibility for In Situ Vaccination.

|Jun 25, 2026
A Virus-Agnostic Cellular Immunomodulatory Platform for Chronic Respiratory Disease: Restoring Immune Competence and Mitigating Exacerbations in the Elderly.

|May 14, 2020
Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak.

Michael Har-Noy, Reuven Or

Pageof 1

Frequent Collaborators